Top Markets
#1 Palladium Network Palladium Network +27.94%
#2 MarsCoin MarsCoin +25.78%
#3 Hive Hive +25.60%
#4 Siren Siren +24.48%
#5 BankrCoin BankrCoin +20.74%
#6 Ankr Network Ankr Network +17.93%
#7 StonkBroker StonkBroker +16.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
#9 Status Status +11.03%
#10 Provenance Blockchain Provenance Blockchain +8.81%
Coin of the day
Palladium Network Palladium Network
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited

TaiGen Biopharmaceuticals Holdings Limited

4157
Classement en actions #18382
TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm... TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm dedicated to pioneering innovative treatments for life-altering diseases. Its robust development pipeline features several key assets. Among these is Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic currently being advanced for the treatment of various bacterial infections, including community-acquired pneumonia and diabetic foot infections. The company is also progressing Burixafor, a stem cell mobilizer with applications in stem cell transplantation and chemosensitization. Further contributing to its portfolio is TG-1000, an antiviral medication designed to combat influenza A, B, and the avian influenza H7N9 strain. Additionally, Furaprevir, a hepatitis C virus (HCV) protease inhibitor, is under development for managing chronic hepatitis C. Established in 2001, TaiGen Biopharmaceuticals maintains its headquarters in Taipei City, Taiwan.
Prix de l'action
$0.28237537
Capitalisation boursière
$201.00M
Changement (1 jour)
0.23%
Changement (1 an)
-9.68%
Pays
TW
Échange TaiGen Biopharmaceuticals Holdings Limited (4157)

Catégorie

Healthcare
Le prix 4157 avec la capitalisation boursière de B
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
4157
$0.28237537
Capitalisation boursière de TaiGen Biopharmaceuticals Holdings Limited(4157)
Capitalisation boursière: $201.00M
En September 2026, TaiGen Biopharmaceuticals Holdings Limited a une capitalisation boursière de $201.00M. Cela fait de TaiGen Biopharmaceuticals Holdings Limited la 18382nd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de TaiGen Biopharmaceuticals Holdings Limited du 2013 au 2026
4157 par rapport au top 5 des plus populaires stocks
Prix pour 4157 L’actif B La capitalisation boursière de B Résultats
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$7,620.17 $201.00M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.424T +2,698,494.30%
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$6,709.27 $201.00M
Apple Inc. Apple Inc.
AAPL
$4.776T +2,375,911.59%
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$5,692.08 $201.00M
Alphabet Inc. Alphabet Inc.
GOOG
$4.052T +2,015,683.73%
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$5,185.25 $201.00M
Microsoft Corporation Microsoft Corporation
MSFT
$3.691T +1,836,197.69%
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$3,855.17 $201.00M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.744T +1,365,165.61%